AXS-05
AXS-05-MDD-201
Approved small_molecule active
Quick answer
AXS-05 for Major Depressive Disorder is a Approved program (small_molecule) at Axsome Therapeutics with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Axsome Therapeutics
- Indication
- Major Depressive Disorder
- Phase
- Approved
- Modality
- small_molecule
- Status
- active